The 3 analysts offering 12-month price forecasts for MiMedx Group Inc have a median target of 11.00, with a high estimate of 16.00 and a low estimate of 8.50. The median estimate represents a +179.19% increase from the last price of 3.94.
The current consensus among 2 polled investment analysts is to Buy stock in MiMedx Group Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.04
Reporting Date Oct 27
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.